• By clicking "OK" or continuing to use this site, you agree that we may collect and use your personal data and set cookies to improve your experience and customise advertising. To see how, and to learn how to control cookies, please read our Privacy Policy and Cookie Policy.
Earlier today
In the last 7 days
Medincell and AbbVie make injectable therapy development deal Pharmaceutical Technology10:23 17-Apr-24
Is AbbVie a Millionaire Maker? The Motley Fool06:24 14-Apr-24
In the last month
AbbVie: Bulletproof Fundamentals Seeking Alpha23:36 12-Apr-24
UK’s NICE recommends AbbVie’s Aquipta to treat migraines Pharmaceutical Technology18:23 11-Apr-24
Oruka Aiming At AbbVie, UCB In Psoriatic Indications Scrip Pharma Intelligence20:16 4-Apr-24
AbbVie to Host First-Quarter 2024 Earnings Conference Call PR Newswire (Press Release)13:04 4-Apr-24
Oruka Aiming At AbbVie, UBC In Psoriatic Indications Scrip Pharma Intelligence23:02 3-Apr-24
Quick Listen: Scrip's Five Must-Know Things Scrip Pharma Intelligence03:31 1-Apr-24
FDA Approve Abbvie Ovarian Cancer Therapy European Pharmaceutical Manufacturer11:31 25-Mar-24
AbbVie Needs To Freshen Up Scrip Pharma Intelligence10:09 22-Mar-24
view more headlines
20 Apr 03:29

AbbVie News

NewsNow aims to be the world's most accurate and comprehensive aggregator of AbbVie news, covering the latest share price, company announcements, vaccine trials, product news and more from the best online publications. Every story from every site is brought to you automatically and continuously 24/7, within around 10 minutes of publication.
Read more

Publication filters

Headline Density

Sorry, no headlines or news topics were found. Please try different keywords.